Cloud DX (TSX-V:CDX, OTCQB:CDXFF) CEO Robert Kaul joined Steve Darling from Proactive to highlighting the company's expanding role in the healthcare sector. Cloud DX has secured two new contracts, one with Ontario Family Health Teams and another a 36-month extension with Oak Valley Health's Markham Stouffville Hospital. The first contract with Ontario Family Health Teams underscores the transformative potential of Cloud DX's Connected Health Remote Patient Monitoring system. This technology allows for palliative care and monitoring to be conducted from the comfort of a patient's home. Patients and their circle of care benefit from the peace of mind that comes with knowing a dedicated clinical team is vigilantly monitoring their loved one's well-being.
This monitoring includes the use of weekly surveys, incorporating tools like patient satisfaction assessments, and PRFS (Palliative Rehabilitation Family Satisfaction) tools to assess the patient's stage in their palliative journey. This contract exemplifies Cloud DX's commitment to enhancing patient care and enabling remote monitoring solutions. The second contract involves the Oak Valley Health's Markham Stouffville Hospital, which has renewed and extended its contract for Cloud DX Remote Patient Monitoring products and services for an additional 36 months. Since November 2017, the hospital has been utilizing Cloud DX solutions for various community care programs, addressing conditions such as chronic obstructive pulmonary disease (COPD), heart failure, and virtual rehabilitation.
Additionally, the Lung Health Foundation has acquired Connected Health Kits for deployment at the hospital. Impressively, many patients at Markham Stouffville Hospital have consistently used Cloud DX technology for over 65 months, showcasing the reliability and effectiveness of the solution. Kaul emphasized the company's commitment to delivering better healthcare outcomes and projected continued growth in 2024, with an emphasis on expanding in the United States. Cloud DX's success is underscored by peer-reviewed papers showcasing the technology's efficacy and patient satisfaction scores exceeding 95%.